
|Videos|July 28, 2016
CINV: Understanding the Guidelines for Recommendations
Advertisement
James Natale, PharmD, BCOP, outlines the guidelines for acute and delayed emesis in patients receiving highly emetic chemotherapy versus moderately emetic chemotherapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
3
FDA Approves Gazyva for Active Lupus Nephritis
4
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
5